Aug 11, 2025 12:00
TOVX - Theriva Biologics, Inc.
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
0.41 0.01 (2.74%) | 0.0 (0.0%) | 0.0 (0.8%) | 0.01 (1.31%) | --- | --- | 0.01 (2.74%) | 0.01 (2.74%) |
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- -1.93
- Diluted EPS:
- -1.93
- Basic P/E:
- -0.2156
- Diluted P/E:
- -0.2156
- RSI(14) 1m:
- 63.41
- VWAP:
- 0.42
- RVol:
- 0.0116
Events
Period | Kind | Movement | Occurred At |
---|
Related News
Dec 24, 2024 11:26
Dec 05, 2024 23:49
Dec 05, 2024 13:00
Nov 01, 2024 18:43
Oct 04, 2024 00:05
Sep 27, 2024 01:06
Aug 17, 2024 16:58
May 24, 2024 01:38
May 23, 2024 12:15